Neuroprotective Effects of Kinetin Against Glutamate-Induced Oxidative Cytotoxicity in HT22 Cells: Involvement of Nrf2 and Heme Oxygenase-1
- 360 Downloads
Oxidative stress is considered as one of key factors related to Alzheimer’s disease (AD), while kinetin (KT) has been reported to exert anti-oxidative activities as well as neuroprotective effects both in vivo and in vitro. Thus, in this study, the neuroprotective effects of KT against glutamate-induced oxidative toxicity in HT22 cells were investigated. To evaluate the anti-oxidative capabilities of KT itself, several anti-oxidative assays in vitro were conducted. To evaluate the neuroprotective effects of KT, the levels of intracellular reactive oxygen species (ROS) and calcium influx, mitochondrial membrane potential (MMP), and cell death were measured by flow cytometry. Nuclear translocation of apoptosis inducing factor (AIF) and content of intracellular ATP were also determined. In addition, the phosphorylation levels of apoptosis signal-regulating kinase 1 (ASK-1), c-Jun N-terminal kinase (JNK), and p38 mitogen-activated protein kinases (p38) were evaluated as well. Besides, nuclear translocation of nuclear factor-E2-related factor 2 (Nrf2) and the expression of heme oxygenase-1 (HO-1) were also examined to reveal underlying mechanisms. Results showed that KT rescued cell death, and suppressed the accumulation of intracellular ROS and the increase of intracellular calcium influx. In addition, KT maintained normal function of mitochondria and inhibited the phosphorylation of ASK-1, JNK, and p38. KT also promoted nuclear translocation of Nrf2 and enhanced the expression of HO-1 both at protein and mRNA level. Importantly, blockage of Nrf2 almost completely abolished the neuroprotective effects of KT, while blockage of HO-1 expression partly neutralized its neuroprotective effects. Our results indicated that KT can protect HT22 cells from glutamate-induced cell death by activating Nrf2 pathway and inducing expression of HO-1, suggesting KT might be a drug candidate for treatment of AD and other neurodegenerative disorders related to oxidative stress.
KeywordsKinetin Glutamate HT22 cells Oxidative stress Nrf2 HO-1
This work was supported by Major Science and Technology Innovation Special Fund of Shaanxi Province (no. K332020916) and Science and Technology Co-ordination Innovation Project of Shaanxi Province (no. K3310216076).
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
- Albrecht P, Lewerenz J, Dittmer S, Noack R, Maher P, Methner A (2010) Mechanisms of oxidative glutamate toxicity: the glutamate/Cystine antiporter system x(c)(−) as a neuroprotective drug target CNS Neurol Disord-Drug. Targets 9:373–382Google Scholar
- Barciszewski J, Rattan SIS, Siboska G, Clark BFC (1999) Kinetin—45 years on Plant Sci 148:37-45 doi: https://doi.org/10.1016/s0168-9452(99)00116-8
- Cooper AJL, Jeitner TM (2016) Central role of glutamate metabolism in the maintenance of nitrogen homeostasis in normal and hyperammonemic brain. Biomolecules:6. https://doi.org/10.3390/biom6020016
- Fujisawa T, Ichijo H (2014) ASK1-MAP kinase signaling pathway as a therapeutic target for human diseases. Nihon rinsho Jpn J Clin Med 72:957–965Google Scholar
- Johnson DA, Johnson JA (2015) Nrf2—a therapeutic target for the treatment of neurodegenerative diseases. Free Radic Biol Med 88:253–267. https://doi.org/10.1016/j.freeradbiomed.2015.07.147 CrossRefPubMedPubMedCentralGoogle Scholar
- Lewerenz J, Maher P (2015) Chronic glutamate toxicity in neurodegenerative diseases—what is the evidence? Front Neurosci 9. https://doi.org/10.3389/fnins.2015.00469
- Li MY, Ouyang WQ, Wu XL, Zheng Y, Gao R, Ouyang X, An L (2014a) Kinetin protects D-galactose-induced aging rats from splenic oxidative damage. Pak Vet J 34:386–390Google Scholar
- Li MY, Ouyang WQ, Li J, Si LF, Li X, Guo JJ, Li HF (2016) Effects of kinetin on thymus and immune function of aging Rats. Pak Vet J 36:356–362Google Scholar
- Liu YM, Zhang ZQ, Yang XF (2011) Kinetin protects against lipid peroxidation and improves antioxidant status in cultured astrocytes and mouse brain exposed to D-galactose. Afr J Biotechnol 10:11721–11727Google Scholar
- Luca M, Luca A, Calandra C (2015) The role of oxidative damage in the pathogenesis and progression of Alzheimer's disease and vascular dementia. Oxid Med Cell Longev. https://doi.org/10.1155/2015/504678
- Rosales-Corral S, Tan DX, Manchester L, Reiter RJ (2015) Diabetes and Alzheimer disease, Two overlapping pathologies with the same background: oxidative stress. Oxid Med Cell Longev. https://doi.org/10.1155/2015/985845
- Son Y, Byun SJ, Pae HO (2013) Involvement of heme oxygenase-1 expression in neuroprotection by piceatannol, a natural analog and a metabolite of resveratrol, against glutamate-mediated oxidative injury in HT22 neuronal cells. Amino Acids 45:393–401. https://doi.org/10.1007/s00726-013-1518-9 CrossRefPubMedGoogle Scholar
- Sun JH, Xiang GQ, Liu YM, Cao T, Li MY, Shang YH, Ouyang WQ (2012) Protective Effect of Kinetin on Iso-Induced Myocardial Ischemia in vitro and in vivo. J Anim Vet Adv 11:4617–4624Google Scholar